{{Rsnum
|rsid=4694362
|Gene=DCK
|Chromosome=4
|position=71028147
|Orientation=plus
|GMAF=0.4665
|Gene_s=DCK
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.3 | 41.1 | 36.6
| HCB | 5.8 | 38.7 | 55.5
| JPT | 2.7 | 28.3 | 69.0
| YRI | 82.6 | 16.7 | 0.7
| ASW | 59.6 | 36.8 | 3.5
| CHB | 5.8 | 38.7 | 55.5
| CHD | 3.7 | 37.6 | 58.7
| GIH | 21.8 | 47.5 | 30.7
| LWK | 72.0 | 27.1 | 0.9
| MEX | 8.6 | 50.0 | 41.4
| MKK | 65.2 | 31.0 | 3.9
| TSI | 16.7 | 52.9 | 30.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22964418
|Title=Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}